- Investing Ideas
- U.S. Pharmaceuticals & Biotech Undervalued Dividend Payers
U.S. Pharmaceuticals & Biotech Undervalued Dividend Payers
Results
4
Companies available at a discount paying at least a 2% dividend yield.
4 companies
Johnson & Johnson
Market Cap: US$584.6b
Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJ
US$243.71
7D
-1.2%
1Y
46.9%
Merck
Market Cap: US$289.5b
Operates as a healthcare company worldwide.
MRK
US$117.09
7D
-2.3%
1Y
23.6%
Gilead Sciences
Market Cap: US$182.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$148.56
7D
0.5%
1Y
29.8%
Qiagen
Market Cap: US$8.9b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QGEN
US$43.00
7D
-9.8%
1Y
4.1%